Search Results

RKI-1447 25mg 25mg  | Purity Not Available

Adooq Bioscience

RKI-1447 is a potent inhibitor of the Rho-associated ROCK kinases with anti-invasive and antitumor activities in breast cancer.

More Information Supplier Page

RKI-1447 10mM * 1mL in DMSO 10mM * 1mL in DMSO  | Purity Not Available

Adooq Bioscience

RKI-1447 is a potent inhibitor of the Rho-associated ROCK kinases with anti-invasive and antitumor activities in breast cancer.

More Information Supplier Page

RKI-1447 10mg 10mg  | Purity Not Available

Adooq Bioscience

RKI-1447 is a potent inhibitor of the Rho-associated ROCK kinases with anti-invasive and antitumor activities in breast cancer.

More Information Supplier Page

SCH 23390 hydrochloride 25mg 25mg  | Purity Not Available

Adooq Bioscience

SCH 23390 hydrochloride is a potent dopamine receptor antagonist (Ki values are 0.2 nM and 0.3 nM at D1 and D5 receptor sub-types, respectively).

More Information Supplier Page

SCH 23390 hydrochloride 10mg 10mg  | Purity Not Available

Adooq Bioscience

SCH 23390 hydrochloride is a potent dopamine receptor antagonist (Ki values are 0.2 nM and 0.3 nM at D1 and D5 receptor sub-types, respectively).

More Information Supplier Page

RKI-1447 50mg 50mg  | Purity Not Available

Adooq Bioscience

RKI-1447 is a potent inhibitor of the Rho-associated ROCK kinases with anti-invasive and antitumor activities in breast cancer.

More Information Supplier Page

CPI-203 10mg 10mg  | Purity Not Available

Adooq Bioscience

CPI203 is a novel potent, selective and cell permeable inhibitor of the bromodomain and extra terminal (BET) family protein BRD4 with an IC50 of ~37 nM (BRD4 ??-screen assay).

More Information Supplier Page